NCT02724735View on ClinicalTrials.gov

A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

UnknownOBSERVATIONAL

Enrollment

220

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions

Major Depressive Disorder

Interventions

DRUG

NSI-189

0 Milligrams, 40 Milligrams or 80 Milligrams administered in the acute study only

Trial Locations (12)

10312

RECRUITING

Staten Island

30005

RECRUITING

Alpharetta

32256

RECRUITING

Jacksonville

32801

RECRUITING

Orlando

38119

RECRUITING

Memphis

45417

RECRUITING

Dayton

63141

RECRUITING

St Louis

75231

RECRUITING

Dallas

78229

RECRUITING

San Antonio

80209

RECRUITING

Denver

91950

RECRUITING

National City

92845

RECRUITING

Garden Grove

Sponsors

Lead Sponsor

Neuralstem Inc.

All Listed Sponsors

lead

Neuralstem Inc.

INDUSTRY